Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • asesay
    Junior Member
    • Jun 2009
    • 2

    #1

    Illumina DSN normalisation

    We are trying to produce a cDNA library for RNA-Seq from 100ng of total RNA using the DSN normalisation protocol from your website. Earlier in the week, we were told to follow the mRNA Sequencing Sample Preparation Guide, starting at 'Fragment the RNA', up to ligation of the adaptors, and then starting the DSN normalisation protocol. However, there doesn't appear to be any size selection if we do it this way, can this be right?

    Also, one of the pdfs on your website suggests that we should enrich the library by PCR before starting DSN normalisation:-

    http://www.illumina.com/documents/se...sequencing.pdf

    Could you help us by clarifying which steps of the mRNA-Seq protocol we should omit when producing a library from 100ng of total RNA?

    Many thanks in advance,

    Abdul
  • ScottC
    Senior Member
    • Jan 2008
    • 244

    #2
    EDIT: Sorry, I misread the post!

    Comment

    • mnkyboy
      Member
      • Mar 2009
      • 87

      #3
      You just skip the poly A selection and start at fragmentation.

      The Amppure beads act as size selection using this protocol.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      68 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...